Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10182)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
COPZ1
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Nuclear receptor coactivator 4 (NCOA4) [Driver]
In total 1 item(s) under this target | |||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
Target for Ferroptosis | Driver | ||||
Responsed Disease | Glioblastoma | ICD-11: 2A00 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Autophagy | hsa04140 | ||||
Cell Process | Cell ferroptosis | ||||
Cell autophagy | |||||
Cell proliferation | |||||
In Vitro Model |
U-87MG cells | Glioblastoma | Homo sapiens | CVCL_GP63 | |
U-251MG cells | Astrocytoma | Homo sapiens | CVCL_0021 | ||
A-172 cells | Glioblastoma | Homo sapiens | CVCL_0131 | ||
LN-229 cells | Glioblastoma | Homo sapiens | CVCL_0393 | ||
T98 cells | Glioblastoma | Homo sapiens | CVCL_B368 | ||
In Vivo Model |
Mice were divided into two groups (10 mice per group) and anesthetized with an intraperitoneal injection (80 uL) containing ketamine HCl (25 mg/mL), xylazine (2.5 mg/mL), and 14.25% ethyl alcohol (diluted 1:3 in 0.9% NaCl). U87MG-NC and U87MG-sh-COPZ1#1 glioma cells (106 cells diluted in 10 uL PBS per animal) were injected into the right frontal lobes of each mouse using the following coordinates: 1 mm anterior and 2.5 mm lateral to the bregma, at a depth of 2 mm.
Click to Show/Hide
|
||||
Response regulation | COPZ1 knockdown also led to the increase in nuclear receptor coactivator 4 (NCOA4), resulting in the degradation of ferritin, and a subsequent increase in the intracellular levels of ferrous iron and ultimately ferroptosis.The COPZ1/NCOA4/FTH1 axis is therefore a novel therapeutic target for the treatment of human glioblastoma. | ||||
Glioblastoma [ICD-11: 2A00]
In total 1 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
Target Regulator | Coatomer subunit zeta-1 (COPZ1) | Protein coding | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Autophagy | hsa04140 | ||||
Cell Process | Cell ferroptosis | ||||
Cell autophagy | |||||
Cell proliferation | |||||
In Vitro Model |
U-87MG cells | Glioblastoma | Homo sapiens | CVCL_GP63 | |
U-251MG cells | Astrocytoma | Homo sapiens | CVCL_0021 | ||
A-172 cells | Glioblastoma | Homo sapiens | CVCL_0131 | ||
LN-229 cells | Glioblastoma | Homo sapiens | CVCL_0393 | ||
T98 cells | Glioblastoma | Homo sapiens | CVCL_B368 | ||
In Vivo Model |
Mice were divided into two groups (10 mice per group) and anesthetized with an intraperitoneal injection (80 uL) containing ketamine HCl (25 mg/mL), xylazine (2.5 mg/mL), and 14.25% ethyl alcohol (diluted 1:3 in 0.9% NaCl). U87MG-NC and U87MG-sh-COPZ1#1 glioma cells (106 cells diluted in 10 uL PBS per animal) were injected into the right frontal lobes of each mouse using the following coordinates: 1 mm anterior and 2.5 mm lateral to the bregma, at a depth of 2 mm.
Click to Show/Hide
|
||||
Response regulation | COPZ1 knockdown also led to the increase in nuclear receptor coactivator 4 (NCOA4), resulting in the degradation of ferritin, and a subsequent increase in the intracellular levels of ferrous iron and ultimately ferroptosis.The COPZ1/NCOA4/FTH1 axis is therefore a novel therapeutic target for the treatment of human glioblastoma. | ||||